BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18395956)

  • 1. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer.
    Zhang XY; Zhang HY; Zhang PN; Lu X; Sun H
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):237-44. PubMed ID: 18395956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
    Xia S; Zhao Y; Yu S; Zhang M
    Cancer Biother Radiopharm; 2010 Jun; 25(3):317-23. PubMed ID: 20578837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
    Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomerase activity,PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line].
    Yu XX; Shi YA; Zhang LH; Wang YS; Wu S
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):323-7. PubMed ID: 18956651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
    Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
    Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo.
    Liu Y; Cui B; Qiao Y; Zhang Y; Tian Y; Jiang J; Ma D; Kong B
    Int J Gynecol Cancer; 2011 Jan; 21(1):100-5. PubMed ID: 21330835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway.
    Feng N; Luo J; Guo X
    Mol Med Rep; 2016 Apr; 13(4):3243-8. PubMed ID: 26936429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
    Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
    Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyr61 expression influences cancer cell proliferation and apoptosis via PI3K pathway in human ovarian carcinoma cells].
    Xiao L; He C; Li X; Chen Y; Zhou JD
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):616-20. PubMed ID: 23141184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Cyperone inhibits the proliferation of human cervical cancer HeLa cells via ROS-mediated PI3K/Akt/mTOR signaling pathway.
    Pei XD; Yao HL; Shen LQ; Yang Y; Lu L; Xiao JS; Wang XY; He ZL; Jiang LH
    Eur J Pharmacol; 2020 Sep; 883():173355. PubMed ID: 32687921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
    Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polydatin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling pathway].
    Pan JH; Wang HB; Du XF; Liu JY; Zhang DJ
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2345-2349. PubMed ID: 28822191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells.
    Li B; Cheung PY; Wang X; Tsao SW; Ling MT; Wong YC; Cheung AL
    Carcinogenesis; 2007 Nov; 28(11):2313-20. PubMed ID: 17638919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
    Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
    Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells.
    Liu JJ; Duan RD
    Anticancer Res; 2009 Aug; 29(8):2987-91. PubMed ID: 19661305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines.
    Wang L; Wu J; Lu J; Ma R; Sun D; Tang J
    Mol Med Rep; 2015 Feb; 11(2):931-9. PubMed ID: 25355053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.